0001209191-23-052997.txt : 20231017
0001209191-23-052997.hdr.sgml : 20231017
20231017183753
ACCESSION NUMBER: 0001209191-23-052997
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231016
FILED AS OF DATE: 20231017
DATE AS OF CHANGE: 20231017
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burgess Michael F.
CENTRAL INDEX KEY: 0001801745
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41747
FILM NUMBER: 231330577
MAIL ADDRESS:
STREET 1: C/O SYNLOGIC, INC.
STREET 2: 301 BINNEY STREET, SUITE 402
CITY: CAMRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Turnstone Biologics Corp.
CENTRAL INDEX KEY: 0001764974
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 832909368
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: 347-897-5988
MAIL ADDRESS:
STREET 1: 920 BROADWAY
STREET 2: 16TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10010
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-10-16
0
0001764974
Turnstone Biologics Corp.
TSBX
0001801745
Burgess Michael F.
C/O TURNSTONE BIOLOGICS CORP.
9310 ATHENA CIRCLE, SUITE 300
LA JOLLA
CA
92037
1
1
0
0
Interim Chief Medical Officer
0
Employee Stock Option (Right to Buy)
2.61
2023-10-16
4
A
0
11464
0.00
A
2033-10-15
Common Stock
11464
11464
D
One fourth (1/4th) of the shares subject to the option award shall vest on October 12, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
/s/ P. Joseph Campisi, Jr., Attorney-in-Fact
2023-10-17